SAMN31276454
External Id
Huaian First People Hospital, Nanjing Medical University
INSDC center name
2022-10-31T00:00:00Z
INSDC first public
2022-10-31T22:27:02.146Z
INSDC last update
SRS15404674
INSDC secondary accession
live
INSDC status
Human
NCBI submission model
Human.1.0
NCBI submission package
SRS15404674
SRA accession
65 years old
age
Huaian First Peoples Hospital, Nanjing Medical University
biomaterial_provider
synchronous multiple primary lung cancer
disease
IIIa (pT2bN2M0)
disease_stage
Han Chinese
ethnicity
Lower left lobe of lung
isolate
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
Tissue sample
sample_type
male
sex
lung cancer tissues
tissue
Left lower lobe
title
Patient received surgery and administration of the second generation ALK inhibitor named Ensartinib hydrochloride with a dose of 225 mg per day.
treatment